Skip to main content
. 2015 Dec 15;7(3):3332–3340. doi: 10.18632/oncotarget.6620

Table 1. Prognostic impact of FAM83D expression level in 18 possible pools corresponding to every combination of populations (nodal and ER status).

LN ER Event status p-value Hazard ratio 95% CI No patients No events
Nm Erm AE < 0.0001 1.34 1.26 - 1.43 2653 909
Nm ER+ MR < 0.0001 1.56 1.41 - 1.71 1198 282
Nm ERm MR < 0.0001 1.44 1.33 - 1.56 1672 425
Nm ER+ AE < 0.0001 1.42 1.31 - 1.54 1897 624
N+ ERm MR < 0.0001 1.56 1.36 - 1.80 439 166
N+ ER+ MR < 0.0001 1.63 1.38 - 1.92 343 118
N- ERm AE < 0.0001 1.38 1.23 - 1.55 1048 299
N- ER+ AE < 0.0001 1.5 1.29 - 1.75 743 213
N+ ERm AE < 0.0001 1.29 1.17 - 1.43 911 406
N- ER+ MR < 0.0001 1.78 1.41 - 2.27 422 78
N+ ER+ AE < 0.0001 1.33 1.18 - 1.51 685 284
N- ERm MR 0.0001 1.42 1.20 - 1.69 590 111
Nm ER- MR 0.0681 1.17 0.99 - 1.38 454 140
Nm ER- AE 0.0878 1.12 0.98 - 1.27 727 278
N- ER- AE 0.0909 1.23 0.97 - 1.56 285 82
N+ ER- MR 0.3033 1.16 0.87 - 1.55 94 48
N- ER- MR 0.7622 1.06 0.74 - 1.51 153 32
N+ ER- AE 0.7638 1.03 0.84 - 1.27 223 122

Node or ER status (+: positive, −: negative, m: mixed); AE: any event; MR: metastatic relapse; HR: hazards ratio.